Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
TLRY 
Tilray Inc (TLRY)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/02/2025: TLRY (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $1.32
1 Year Target Price $1.32
| 4 | Strong Buy |
| 0 | Buy |
| 8 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -32.97% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 499.03M USD | Price to earnings Ratio - | 1Y Target Price 1.32 |
Price to earnings Ratio - | 1Y Target Price 1.32 | ||
Volume (30-day avg) 12 | Beta 1.93 | 52 Weeks Range 0.35 - 2.15 | Updated Date 07/2/2025 |
52 Weeks Range 0.35 - 2.15 | Updated Date 07/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.1 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -114.4% | Operating Margin (TTM) -16.76% |
Management Effectiveness
Return on Assets (TTM) -1.63% | Return on Equity (TTM) -30.73% |
Valuation
Trailing PE - | Forward PE 1000 | Enterprise Value 594525618 | Price to Sales(TTM) 0.6 |
Enterprise Value 594525618 | Price to Sales(TTM) 0.6 | ||
Enterprise Value to Revenue 0.72 | Enterprise Value to EBITDA -4.84 | Shares Outstanding 1028499968 | Shares Floating 990177495 |
Shares Outstanding 1028499968 | Shares Floating 990177495 | ||
Percent Insiders 0.69 | Percent Institutions 10.1 |
Analyst Ratings
Rating 3 | Target Price 1.32 | Buy - | Strong Buy 4 |
Buy - | Strong Buy 4 | ||
Hold 8 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Tilray Inc
Company Overview
History and Background
Tilray, Inc. was founded in 2018 through the merger of Aphria and Tilray. Aphria was founded in 2014 in Canada. Tilray's roots extend back to the early days of the legalized cannabis industry, focusing on medical cannabis before expanding into recreational markets.
Core Business Areas
- Cannabis: Cultivation, processing, and distribution of cannabis products for medical and recreational use. Products include dried flower, oils, edibles, and vapes.
- Beverage Alcohol: Production and distribution of alcoholic beverages, primarily beer and spirits, through acquisitions of beverage brands.
- Distribution: Distribution of pharmaceutical and wellness products through CC Pharma, a leading pharmaceutical distributor in Europe.
Leadership and Structure
Irwin D. Simon is the Chairman and CEO. The company has a standard corporate structure with various executive vice presidents overseeing different business areas. A board of directors provides governance and strategic oversight.
Top Products and Market Share
Key Offerings
- Cannabis Flower: Dried cannabis flower for smoking or vaping. Market share fluctuates based on region and product offerings. Competitors include Canopy Growth, Curaleaf, and Green Thumb Industries.
- Cannabis Oils and Extracts: Cannabis extracts and oils used for various applications. Market share varies. Competitors include Canopy Growth, Curaleaf, and Green Thumb Industries.
- SweetWater Brewing Company: Craft beer brand acquired by Tilray. A leader in the craft beer market in the Southeast United States. Competitors include Boston Beer Company (Sam Adams), Anheuser-Busch InBev, and Molson Coors.
- Breckenridge Distillery: Distillery acquired by Tilray. A leader in the whiskey market in Colorado United States. Competitors include Brown-Forman, Diageo and Beam Suntory
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth, driven by legalization and increasing consumer acceptance. The alcoholic beverage sector is mature and highly competitive.
Positioning
Tilray aims to be a global leader in cannabis and a major player in the beverage alcohol sector. Its competitive advantages include its diversified portfolio, global reach, and strong brands.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars. The beverage alcohol market is also substantial. Tilray is positioned to capture a portion of both markets through expansion and acquisitions.
Upturn SWOT Analysis
Strengths
- Diversified business segments
- Global presence and distribution network
- Brand portfolio (Cannabis and Alcohol)
- Strategic acquisitions
- Strong management team
Weaknesses
- Inconsistent Profitability
- High Operating Expenses
- Volatile stock price
- Debt levels
- Integration challenges from acquisitions
Opportunities
- Further cannabis legalization globally
- Expansion into new markets
- Development of innovative cannabis products
- Increased focus on medical cannabis
- Strategic partnerships and acquisitions
Threats
- Regulatory uncertainty
- Intense competition
- Fluctuations in cannabis prices
- Economic downturn
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- CGC
- CRLBF
- GTBIF
- SMG
Competitive Landscape
Tilray faces intense competition in both the cannabis and beverage alcohol markets. Its advantages include its diversified portfolio and global reach. Its disadvantages include inconsistent profitability.
Major Acquisitions
SweetWater Brewing Company
- Year: 2020
- Acquisition Price (USD millions): 300
- Strategic Rationale: Diversified Tilray's portfolio into the beverage alcohol sector, providing a platform for further expansion.
Breckenridge Distillery
- Year: 2021
- Acquisition Price (USD millions): 50
- Strategic Rationale: Expand and further Diversified Tilray's portfolio into the beverage alcohol sector, providing a platform for further expansion.
Growth Trajectory and Initiatives
Historical Growth: Tilray has experienced significant revenue growth through acquisitions and expansion. Profitability has been inconsistent.
Future Projections: Analyst estimates vary, but generally project continued revenue growth driven by the expansion of the cannabis industry and Tilray's strategic initiatives.
Recent Initiatives: Recent initiatives include expanding its cannabis footprint in Europe, launching new cannabis products, and integrating acquired businesses.
Summary
Tilray has strategically positioned itself to be a global leader in cannabis and a significant player in beverage alcohol through acquisitions and expansion. Profitability remains a challenge despite strong revenue growth. Regulatory changes and intense competition are ongoing risks, but the company's diversified portfolio offers resilience. Strategic execution and market adaptation are vital for Tilray's success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Industry Reports
- Financial News Outlets
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market conditions are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Tilray Inc
Exchange NASDAQ | Headquaters Leamington, ON, Canada | ||
IPO Launch date 2018-07-19 | President, CEO & Chairman Mr. Irwin David Simon | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 2650 | Website https://www.tilray.com |
Full time employees 2650 | Website https://www.tilray.com | ||
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.